Clinical Trials on FMR1-related Primary Ovarian Insufficiency
Total 15588 results
-
Frederick R. Ueland, M.D.Lucille P. Markey Cancer Center at University of KentuckyCompletedOvarian NeoplasmsUnited States
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedOvarian CancerChina, United States, Belgium, Austria, Italy, Australia, France, Germany, Japan, Norway, Spain, Sweden, Korea, Republic of, Hong Kong, Denmark, Ireland, Taiwan
-
University of VirginiaUnknownOvarian CancerUnited States
-
Philipps University Marburg Medical CenterGerman Research FoundationCompletedOvarian CancerGermany, Italy, Austria, Belgium, Czechia, Korea, Republic of
-
Khyber Medical University PeshawarCompletedPolycystic Ovarian SyndromePakistan
-
University of VirginiaUnknown
-
Eli Lilly and CompanyCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterCompleted
-
Cairo UniversityUnknown
-
Celgene CorporationPrologue Research InternationalCompletedOvarian CancerUnited States
-
Boehringer IngelheimCompletedOvarian NeoplasmsBelgium, France, Slovakia, Spain, Sweden
-
Seagen Inc.TerminatedOvarian NeoplasmsUnited States
-
New Mexico Cancer Care AllianceCompleted
-
TelikCompletedOvarian NeoplasmsUnited States
-
British Columbia Cancer AgencyCompleted
-
SanofiCompletedOvarian NeoplasmsTurkey
-
National Cancer Institute (NCI)Completed
-
EugoniaUnknownPolycystic Ovary Syndrome | Ovarian Hyperstimulation SyndromeGreece
-
Celgene CorporationPrologue Research InternationalTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedFallopian Tube Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Malignant Ovarian Brenner Tumor and other conditionsUnited States
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Jiao...RecruitingFallopian Tube Cancer | Primary Peritoneal Carcinoma | Ovarian Cancer RecurrentChina
-
Floor BackesEisai Inc.CompletedFallopian Tube Carcinoma | Recurrent Endometrial Cancer | Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
-
National Cancer Institute (NCI)CompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmsUnited States
-
Medical Research CouncilCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Australia, United Kingdom, Norway, Germany
-
SOTIO a.s.CompletedOvarian Neoplasms | Ovarian Epithelial Cancer | Ovarian Cancer (OvCa)Czechia, Poland, Germany
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Paul Speiser, Prof.MD,CompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Czechia, Germany, Ireland
-
Gradalis, Inc.CompletedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchHoffmann-La Roche; PharmaMarCompletedOvarian Epithelial Cancer RecurrentItaly
-
Jonsson Comprehensive Cancer CenterTetraLogic Pharmaceuticals; California Institute for Regenerative Medicine... and other collaboratorsWithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous AdenocarcinomaUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology GroupRecruitingEpithelial Ovarian CancerJapan, Korea, Republic of
-
Tesaro, Inc.Completed
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Baylor Research InstituteActive, not recruitingEpithelial Ovarian CancerUnited States
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology...CompletedEpithelial Ovarian CancerTaiwan
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina
-
Splash Pharmaceuticals, Inc.UnknownOvarian Epithelial CancerUnited States
-
Assiut UniversityUnknown
-
Dr Thumuluru Kavitha MadhuriCompletedEpithelial Ovarian CancerUnited Kingdom
-
Verastem, Inc.Terminated
-
Allife Medical Science and Technology Co., Ltd.UnknownEpithelial Ovarian Cancer
-
University of California, DavisNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Yonsei UniversityCompletedAdvanced-stage Ovarian CancerKorea, Republic of